Identifying Co-Exposure to Opiates and Gabapentin During Pregnancy.
Where this comes from
- Record sourced from PubMed, PMID 31668481.
- Also identified by DOI 10.1016/j.jpeds.2019.09.029 and PMC identifier 7503060.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Neonatal withdrawal can be difficult to treat in infants with co-exposure to opiates and gabapentin. Because maternal self-report can underestimate exposures, we evaluated the effect of universal toxicology screening for gabapentin. Identification of co-exposure to opiates and gabapentin increased after implementation of toxicology screening, with implications for improved neonatal care.
Medical subject headings
- Gabapentin
- Neonatal Abstinence Syndrome
- Opiate Alkaloids
- Prenatal Exposure Delayed Effects